International Journal of Molecular Sciences — Section Editors

Journal Contact

IJMS Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Section Editorial Boards

Biochemistry, Molecular Biology and Biophysics

Molecular Pathology

Molecular Toxicology

Molecular Diagnostics

Molecular Recognition

Material Sciences and Nanotechnology

Physical Chemistry, Theoretical and Computational Chemistry

Bioactives and Nutraceuticals

Green Chemistry

Bioinorganic Chemistry

Section Board for 'Molecular Pathology'

Please see the section webpage for more information on this section.

Section Editor-in-Chief
Prof. Dr. Kurt A. Jellinger
Institute of Clinical Neurobiology, Alberichgasse 5/13, A1150 Wien, Austria
Fax: +43 1 5266534
Interests: Alzheimer disease; classification of proteinopathies; dementia; dementia with Lewy bodies; immunohistochemistry; Lewy bodies; mild cognitve impairment; movement disorders; multiple system atrophy; neurodegeneration; neuropathology; Parkinson disease; pathogenesis of dementia and movement disorders; pathology and diagnosis of dementia and movement disorders; tau-pathology; vascular dementia; α-synuclein pathology
Contribution: Special Issue: Advances in Molecular Neuropathology
Special Issue: Mechanisms of Neurodegeneration
Prof. Dr. Xiaofeng Jia
Department of Neurosurgery, University of Maryland School of Medicine; Department of Biomedical Engineering; Physical Medicine and Rehabilitation; Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine 10 South Pine Street, MSTF RM 5-59, Baltimore, MD 21201
Interests: brain monitoring and therapeutic hypothermia; peripheral nerve injury and regeneration; translational therapeutic model for neurological injuries; development and characterization of biomaterials for bone and peripheral nerve regeneration
Contribution: Special Issue: Neurological Injuries’ Monitoring, Tracking and Treatment
Dr. William Chi-shing Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
Interests: cancer biomarker; Chinese medicine; diabetes mellitus; evidence-based medicine; genomics; microRNA; molecular diagnostics; nasopharyngeal carcinoma; non-small cell lung cancer; proteomics
Contribution: Special Issue: Advances in Molecular Oncology (special issue)
Special Issue: Advances in Cancer Diagnosis
Special Issue: Molecular Classification of Human Cancer and Its Role in Tailored Cancer Therapy
Special Issue: Advances in Molecular Oncology 2014
Topical Collection: Advances in Molecular Oncology
Special Issue: Molecular Classification of Human Cancer: Diagnosis and Treatment
Special Issue: MicroRNA in Various Disease States as Biomarkers
In other journals:
Special Issue: Recent Advance in Targeted Therapy in Medicine
Special Issue: Acupuncture – Basic Research and Clinical Application
Prof. Michael Henein
Department of Public Health and Clinical Medical and Heart Center, Umea University, Umea, Sweden
Tel. +46 90 785 00 00; Fax: +46 90 13 76 33
Interests: Non-invasive cardiology; Echocardiography; Coronary artery disease imaging; Carotid atherosclerosis
Contribution: Special Issue: Atherosclerosis and Vascular Imaging
Prof. Dr. Johannes Haybaeck
Institute of Pathology, Medical University of Graz, 8036 Graz, Austria
Tel. +43 316 385 80594
Interests: molecular pathology; neuropathology; hepatopathology; tumor animal models
Contribution: Topical Collection: Molecular Mechanisms of Human Liver Diseases
Prof. Dr. Michael R. Hamblin
Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA
BAR 407, Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom Street, Boston, MA 02114, USA
Tel. 6177266182; Fax: +1 617 726 6643
Interests: photodynamic therapy; low level laser (light) therapy; antimicrobial photoinactivation; photochemical mechanisms; anti-tumor immunity
Contribution: Special Issue: Advances in Photodynamic Therapy
Dr. Joseph V. Moxon
The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, School of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia
Interests: peripheral vascular disease, aortic aneurysm, biomarkers, proteomics, systems biology, mouse models, translational research
Contribution: Special Issue: Advances in Peripheral Artery Disease
Prof. Dr. Anthony Lemarié
Research Team: Tumor radioresistance, from signalling pathways to therapy Department of Experimental Therapeutics Inserm U1037 Toulouse Cancer Research Center (CRCT) & IUCT 2 av. Hubert Curien, 31100 Toulouse, France
Interests: cell death; apoptosis; cellular differentiation; cellular and mitochondrial metabolism; cellular and mitochondrial homoeostasis; oxidative stress; cancer; cancer stem cells; glioma; radiotherapy & radioresistance
Contribution: Special Issue: Programmed Cell Death and Apoptosis 2013
Topical Collection: Programmed Cell Death and Apoptosis
Special Issue: Programmed Cell Death and Apoptosis
Prof. Dr. Nicholas Delihas
Department of Molecular Genetics and Microbiology, School of Medicine, 158 Life Sciences Building, Stony Brook University, Stony Brook, NY 11794, USA
Fax: +1 631 632 9797
Interests: regulation of gene expression by small RNAs; add- analysis of functions of non-coding genomic regions of human chromosomes; repetitive sequences in human chromosome 22
Contribution: Special Issue: Regulation by non-coding RNAs 2013
Prof. Dr. Sanjay K. Srivastava
Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA
Interests: environmental carcinogen-induced cell signaling pathways and chemical carcinogenesis; discovery of novel drug targets (STAT-3, NF-kB, HER2, MCL-1, AKT/FOXO, GLI1/2) and their signaling pathways and drug leads such as capsaicin, piperlongumine, penfluridol, isothiocyanates, diindolylmethane, panabinostat and vemurafinib in pancreatic, ovarian, breast, melanoma and brain cancer
Contribution: Special Issue: Bioactive Phytochemicals in Functional Foods for Cancer Prevention
Prof. Dr. Dario Marchetti
Director, Center of the Biomarker Research Program at Houston Methodist Research Institute, and Professor of Pathology and Genomic Medicine at Methodist Hospital, MS: R7-102, 6670 Bertner Avenue, Houston, TX 77030, USA
Interests: the biology and therapeutic utility of circulating tumor cells (CTCs); mechanisms of brain metastasis; breast cancer dormancy; roles of heparanase in development and disease
Contribution: Special Issue: Brain Metastasis
Special Issue: Brain Metastasis 2014
Special Issue: Circulating Tumor Cells
Prof. Dr. Cesar Borlongan
Department of Neurosurgery, MDC 78, University of South Florida College Medicine, Tampa, FL 33612, USA
Interests: stem cell therapy; stroke, neonatal hypoxic-ischemic injury; Parkinson's disease; traumatic brain injury; translational research
Contribution: Special Issue: Pathology and Treatment of Central Nervous System Diseases
Prof. Dr. Philip Newton Baker
1 Director – Gravida: National Centre for Growth and Development, Professor of Maternal and Fetal Health, Consultant Obstetrician and Senior Scientist, The University of Auckland, Level 2, Building 505, 85 Park Rd, Grafton, Private Bag 92019, Auckland 1142, New Zealand
2 Research Professor, Institute of Science and Technology & Medicine, Keele University, UK
3 Distinguished Professor, Chongqing Medical University, Chongqing, China
Interests: Preeclampsia, fetal growth restriction, pregnancy, placenta, metabolomics
Contribution: Special Issue: Prediction, Diagnostics and Prevention of Pregnancy Complications
Special Issue: Metabolomic Technologies in Medicine
Dr. Terrence Piva
School of Medical Sciences, RMIT University, PO Box 71 Bundoora, Victoria 3083, Australia
Tel. +61-3-99256503; Fax: +61 3 9925 7063
Interests: cell death; photobiology; photoimmunology; skin cancer; enzymology; cell metabolism; oxidative stress; cancer metabolism; cell signalling; cytokines; inflammation; enzyme kinetics; metal oxide nanoparticles; sunscreens
Contribution: Special Issue: UV-Induced Cell Death
Special Issue: UV-Induced Cell Death 2012
Topical Collection: Radiation Toxicity in Cells
Prof. Dr. J. Michael Wyss
Departments of Cell Biology and Medicine, University of Alabama, Birmingham, AL, USA
Interests: neuron; neuronal plasticity; central nervous system in the pathogenesis of hypertension
Prof. Dr. Denis Girard
Laboratory of Research in Inflammation and Physiology of Granulocytes, INRS-Institut Armand-Frappier, 531 des Prairies blvd, Laval, Quebec, Canada
Fax: +1 450 686 5309
Interests: inflammation, Cytokines/chemokines, receptors, granulocytes, neutrophils, eosinophils, apoptosis, caspases,cell signalling, protein synthesis, phagocytosis, oxidative burst, cell adhesion, degranulation, cytoskeleton, FACS, Western blot, immunoprecipitation 1D and 2D-SDS-PAGE, RT-PCR, Immunofluorescence, ELISA, in vivo model of inflammation
Dr. Katalin Prokai-Tatrai
Department of Pharmacology & Neuroscience, and Department of Pharmaceutical Sciences, University of North Texas; Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA
Fax: +1 817 735 2118
Interests: medicinal chemistry: drug design of central nervous system agents; neuropeptides and peptidomimetics; prodrugs for CNS delivery; oxidative stress; estrogens and other phenolic antioxidants; protein carbonylation
Contribution: Special Issue: Neuroprotective Strategies (special issue)
Special Issue: Neuroprotective Strategies 2012
Special Issue: Neuroprotective Strategies 2014
Topical Collection: Neuroprotective Strategies
Special Issue: Neuroprotective Strategies 2015
In other journals:
Special Issue: Neuroprotective Strategies
Prof. Harry A. J. Struijker-Boudier
Department of Pharmacology, CARIM, Maastricht University, 616, Maastricht, 6200 MD, The Netherlands
Interests: hypertension, heart failure, microcirculation, antihypertensive drugs, renin-angiotensin system
Dr. Bruno Vincenzi
University Campus Bio-Medico, Medical Oncology, Via Alvaro del Portillo 200, 00128 Rome, Italy
Fax: +39 0622541445
Interests: angiogenesis; targeted therapy; molecular pathways in cancer; molecular predictive and prognostic factors in cancer
Prof. Dr. Jack A. Schalken
Research Director Urology, Dept. of Urology, University Hospital Nijmegen, Box 9101, Nijmegen NL-6500 HB, The Netherlands
Interests: molecular and cellbiology of oncological diseases; cadherine mediated interactions and signal transductions; molecular diagnostics; urogenital oncology; veterinary oncology
Contribution: Special Issue: Molecular Research in Urology
Special Issue: Molecular Research in Urology 2014
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert